Cancer is one of the major causes of death and a significant obstacle to increasing life
expectancy worldwide. Chemotherapy remains the first-line adjuvant therapeutic option for …

Breast cancer (BC) has been ranked the most common malignant tumor throughout the
world and is also a leading cause of cancer-related deaths among women. SRC family …

Cancer is one of the dreadful diseases worldwide. Surgery, radiation and chemotherapy, are
the three basic standard modes of cancer treatment. However, difficulties in cancer treatment …

Simple Summary Despite the increased use of neoadjuvant chemotherapy in the early
setting of breast cancer, there is a clinical need for predictive markers of response in daily …

Breast cancer is the most common malignancy and the second most common cause of
cancer-related mortality in women. Triple-negative breast cancers do not express estrogen …

Asparagine endopeptidase (AEP) is ubiquitously expressed in both physiological and
pathological contexts, yet its precise role and functional mechanism in breast cancer remain …

Triple-negative breast cancer (TNBC) is usually the most malignant and aggressive
mammary epithelial tumor characterized by the lack of expression for estrogen receptors …

Triple-negative breast cancer (TNBC) constitutes a heterogeneous group of malignancies
that are often aggressive and associated with a poor prognosis. The development of new …

Introduction Patients with high-risk, triple negative breast cancer (TNBC) often receive
neoadjuvant chemotherapy (NAC) alone or with immunotherapy. Various single-cell and …

Triple-negative breast cancer (TNBC), the most aggressive form of breast cancer, presents
severe threats to women's health. Therefore, it is critical to find novel treatment approaches …